Guardion Health Sciences, Inc. Announces 1-for-50 Reverse Stock Split Effective on Pre-Market Opening on January 9, 2023
January 06, 2023 16:15 ET
|
Guardion Health Sciences, Inc.
HOUSTON, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) announced today that it will effect a 1-for-50 reverse split of its common...
Guardion Health Sciences Announces Pricing of Aggregate $4.75 Million Institutional Private Placement of Series C and Series D Redeemable Preferred Stock
November 29, 2022 17:06 ET
|
Guardion Health Sciences, Inc.
HOUSTON, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a clinical nutrition company that offers a portfolio of science-based,...
Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2022
November 14, 2022 08:25 ET
|
Guardion Health Sciences, Inc.
Viactiv® Generated Net Revenues of Approximately $2.6 Million or 96% of Net Revenues for the Quarter Ended September 30, 2022 Company Announces Program to Evaluate Strategic Alternatives HOUSTON,...
Guardion Health Sciences Announces Clinical Results Indicating that Viactiv® Omega Boost™ Gel Bites Increase Omega-3 Levels in Just 4 weeks
October 06, 2022 08:00 ET
|
Guardion Health Sciences, Inc.
New Viactiv Omega Boost™ Gel Bites Clinically Proven to Increase Omega-3 Levels by 51% in Just 4 Weeks First-Ever Clinically Proven Gel Bites, with a Tasty Fruit Flavor and No Fish Burps, are a...
Guardion Health Sciences Announces Financial Results for the Quarter Ended June 30, 2022
August 11, 2022 08:20 ET
|
Guardion Health Sciences, Inc.
HOUSTON, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based,...
ISS Recommends Guardion Stockholders Vote for the Increase in Shares for Equity Plan and for the Reverse Stock Split at Guardion’s Upcoming 2022 Annual Stockholders’ Meeting
June 09, 2022 09:00 ET
|
Guardion Health Sciences, Inc.
HOUSTON, June 09, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) announced that independent proxy advisory firm ISS recommends that Guardion...
Guardion Health Sciences Announces Agreement with OmegaQuant Laboratories
June 01, 2022 08:38 ET
|
Guardion Health Sciences, Inc.
HOUSTON, June 01, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced an agreement with OmegaQuant Laboratories (“OmegaQuant”) to provide...
Guardion Health Sciences Announces New Viactiv Omega Boost Gel Bites Now Available for Purchase on Amazon
May 26, 2022 09:00 ET
|
Guardion Health Sciences, Inc.
Consumers May Now Purchase Viactiv Omega Boost 1,200 mg Omega-3 Gel Bites Directly from Amazon Viactiv Omega Boost Gel Bites Provide 10x More Omega-3 Than the Leading Fish Oil Gummy, Without...
Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2022
May 12, 2022 08:13 ET
|
Guardion Health Sciences, Inc.
HOUSTON, May 12, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based,...
Guardion Health Sciences to Present at the Planet MicroCap Showcase 2022
May 03, 2022 15:45 ET
|
Guardion Health Sciences, Inc.
HOUSTON, May 03, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements,...